Kwangdong Pharmaceutical says Chairman Choi Sung-won keeps 19.42% stake after contract extension disclosure
Bitget2026/10/12 08:40- Choi Seong-won filed an amended major-shareholding report in Kwangdong Pharmaceutical, citing an extension of share-pledge contracts.
- Total holdings were unchanged at 9,670,292 shares, equal to 19.42% as of Oct. 12, 2026.
- Shares under key contracts were unchanged at 1,486,560 shares, equal to 2.99%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Inflation surpasses expectations, impacting small-cap stocks; Russell 2000 drops nearly 2%, confirming a technical correction
On Wednesday, approximately four-fifths of the constituents in the Russell 2000 Index recorded declines. Since its peak in August, the index has dropped by 11%, falling below its 200-day moving average and entering a technical correction for the first time since March this year. Analysis indicates that with the US CPI rising more than expected and the probability of rate hikes increasing, small-cap, consumer, and transportation stocks are facing "sustained and long-term resistance."
Inflation and interest rates hit simultaneously, Russell 2000 plunges 11% from August high, marking its first technical correction since March
With both inflation and interest rates rising, the Russell 2000 has fallen 11% from its August peak, breaking below its 200-day moving average and recording its first technical correction since March.
Tesla (TSLA.US) and SpaceX (SPCX.US) merger countdown? Barclays: Announcement possible this year, obstacle lies in shareholder voting
Barclays analysts stated that a potential merger between Elon Musk's Tesla and SpaceX could be announced before the electric vehicle manufacturer's annual shareholder meeting.
Crypto prices
More
